Entertainment One (ETO): Results of Placing
Stock down 1.2% as at 08:10
Shares amounting to 4% of equity capital were placed at a 2.3% discount.
Read more...EMIS Group PLC (EMIS): Update re: NHS Wales GP framework agreement
Stock down 4.5% as at 08:10
EMIS Group has not been chosen as preferred vendor for primary care framework in Wales. Annual revenues of £2m to taper off until 2020.
Read more...Avanti Communications Group (AVN): Trading Update for the three months to 30 September 2017
Stock up 10.9% as at 08:10
AVN records negative EBITDA of $3.8m in first quarter despite revenues of $9.7m
Read more...Cohort PLC (CHRT): SEA awarded Soldier System Research and Development contract
Stock up 0.1% as at 08:10
CHRT wins contract with UK government agency with a potential total value in excess of £3m.
Read more...YouGov PLC (YOU): Pre-Close Trading Update for 6 months ending 31 January 2018.
Stock up 6.8% as at 08:10
Half year trading anticipated to be ahead of previous expectations.
Read more...Severfield PLC (SFR): Board & C-Level Management Changes
Stock down 1.2% at 08:31
Effective from 1 February 2018, interim CEO & CFO to be retained on a permanent basis while Ian Lawson, the architect of Group strategy since 2013, stands down from the Board of Directors due to ill health which has been well advertised since March 2017.
Read more...WANdisco Plc (WAND): New sales partnership with Bytes Technology Group UK
Stock up 3.9% at 08:31
WANdisco Fusion has been chosen as the standard cloud migration solution for Bytes’ UK customers. Bytes is Microsoft’s largest partner in the UK and has an impressive client roster. The agreement significantly expands WANdisco’s sales channel opportunities.
Read more...Avon Rubber PLC (AVON): US Department of Defense Mask Systems Order
Stock up 1.9% at 08:31
US Department of Defense orders $12.6m worth of M50 masks, adding to FY2019 order book.
Read more...F&C Managed Portfolio Trust (FMPG/FMPI): Half-year Report
Growth shares down 0.1%, Income shares down 1.8% as at 08:16
Exposure to Japanese & Asia Pacific markets and biotechnology & technology sectors major themes in outperformance of trust versus FTSE All-Share.
Read more...ReNeuron Group plc (RENE): Positive long-term data from Phase II stroke disability clinical trial.
Stock down 0.2% as at 08:16
Positive long-term data from Phase II stroke disability clinical trial. The FDA has given regulatory approval for the Company to commence a Phase IIb clinical study in the US. Data from the study are expected in late 2019.
Read more...